• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未分化多形性肉瘤的自然史:来自美国肉瘤协作组的经验。

Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.

机构信息

Surgical Oncology, Stanford University, Stanford, California, USA.

Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.

出版信息

J Surg Oncol. 2024 Jun;129(7):1354-1363. doi: 10.1002/jso.27620. Epub 2024 Apr 1.

DOI:10.1002/jso.27620
PMID:38562002
Abstract

BACKGROUND

Undifferentiated pleomorphic sarcoma (UPS) is a relatively rare but aggressive neoplasm. We sought to utilize a multi-institutional US cohort of sarcoma patients to examine predictors of survival and recurrence patterns after resection of UPS.

METHODS

From 2000 to 2016, patients with primary UPS undergoing curative-intent surgical resection at seven academic institutions were retrospectively reviewed. Epidemiologic and clinicopathologic factors were reviewed by site of origin. Overall survival (OS), recurrence-free survival (RFS), time-to-locoregional (TTLR), time-to-distant recurrence (TTDR), and patterns of recurrence were analyzed.

RESULTS

Of the 534 UPS patients identified, 53% were female, with a median age of 60 and median tumor size of 8.5 cm. The median OS, RFS, TTLR, and TTDR for the entire cohort were 109, 49, 86, and 46 months, respectively. There were no differences in these survival outcomes between extremity and truncal UPS. Compared with truncal, extremity UPS were more commonly amenable to R0 resection (87% vs. 75%, p = 0.017) and less commonly associated with lymph node metastasis (1% vs. 6%, p = 0.031). R0 resection and radiation treatment, but not site of origin (extremity vs. trunk) were independent predictors of OS and RFS. TTLR recurrence was shorter for UPS resected with a positive margin and for tumors not treated with radiation.

CONCLUSION

For patients with resected extremity and truncal UPS, tumor size >5 cm and positive resection margin are associated with worse survival OS and RFS, irrespectively the site of origin. R0 surgical resection and radiation treatment may help improve these survival outcomes.

摘要

背景

未分化多形性肉瘤(UPS)是一种相对罕见但具有侵袭性的肿瘤。我们试图利用美国多机构肉瘤患者队列研究 UPS 切除术后生存和复发模式的预测因素。

方法

从 2000 年至 2016 年,回顾性分析了在七所学术机构接受根治性手术切除的原发性 UPS 患者。根据起源部位分析了流行病学和临床病理因素。分析了总生存(OS)、无复发生存(RFS)、局部区域复发时间(TTLR)、远处复发时间(TTDR)和复发模式。

结果

在 534 例 UPS 患者中,53%为女性,中位年龄为 60 岁,中位肿瘤大小为 8.5cm。整个队列的中位 OS、RFS、TTLR 和 TTDR 分别为 109、49、86 和 46 个月。肢体和躯干 UPS 的这些生存结果没有差异。与躯干 UPS 相比,肢体 UPS 更能进行 R0 切除(87%比 75%,p=0.017),且淋巴结转移较少(1%比 6%,p=0.031)。R0 切除和放疗,而不是起源部位(肢体与躯干),是 OS 和 RFS 的独立预测因素。R0 切除和未接受放疗的 UPS 肿瘤,其局部区域复发时间更短。

结论

对于接受过肢体和躯干 UPS 切除的患者,肿瘤大小>5cm 和阳性切缘与较差的 OS 和 RFS 相关,而与起源部位无关。R0 手术切除和放疗可能有助于改善这些生存结果。

相似文献

1
Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.未分化多形性肉瘤的自然史:来自美国肉瘤协作组的经验。
J Surg Oncol. 2024 Jun;129(7):1354-1363. doi: 10.1002/jso.27620. Epub 2024 Apr 1.
2
Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.评估新辅助化疗在原发性高风险躯干/肢体软组织肉瘤中的作用:美国肉瘤协作多机构分析。
Ann Surg Oncol. 2019 Oct;26(11):3542-3549. doi: 10.1245/s10434-019-07639-7. Epub 2019 Jul 24.
3
High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.高社区水平社会脆弱性与肢体和躯干软组织肉瘤切除后无复发生存(RFS)较差相关。
Ann Surg Oncol. 2024 Jun;31(6):4138-4147. doi: 10.1245/s10434-024-15074-6. Epub 2024 Feb 23.
4
Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.未分化多形性肉瘤:不良预后的预测因素。
J Am Acad Dermatol. 2018 Nov;79(5):853-859. doi: 10.1016/j.jaad.2018.05.022. Epub 2018 May 19.
5
Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis.肢体高级别软组织肉瘤切除术切缘对结局的影响:美国外科肿瘤学会分析。
J Surg Oncol. 2021 Feb;123(2):479-488. doi: 10.1002/jso.26275. Epub 2020 Nov 4.
6
Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.高级躯干和四肢软组织肉瘤辅助化疗的使用趋势。
J Surg Res. 2020 Jan;245:577-586. doi: 10.1016/j.jss.2019.08.002. Epub 2019 Sep 5.
7
The clinical outcomes of undifferentiated pleomorphic sarcoma (UPS): A single-centre experience of two decades with the assessment of PD-L1 expressions.未分化多形性肉瘤(UPS)的临床结果:单中心二十年经验及 PD-L1 表达评估。
Eur J Surg Oncol. 2020 Jul;46(7):1287-1293. doi: 10.1016/j.ejso.2020.02.029. Epub 2020 Feb 24.
8
Predicting the prognosis of undifferentiated pleomorphic soft tissue sarcoma: a 20-year experience of 266 cases.未分化多形性软组织肉瘤的预后预测:266例患者的20年经验
ANZ J Surg. 2019 Sep;89(9):1045-1050. doi: 10.1111/ans.15348. Epub 2019 Jul 30.
9
Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.未分化多形性肉瘤中影响肿瘤学结局的临床和分子因素分析
Ann Surg Oncol. 2016 Jul;23(7):2220-8. doi: 10.1245/s10434-016-5115-5. Epub 2016 Feb 3.
10
Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.软组织未分化多形性肉瘤中肌源性分化的预后价值。
Hum Pathol. 2014 Jul;45(7):1504-8. doi: 10.1016/j.humpath.2014.03.002. Epub 2014 Mar 26.

引用本文的文献

1
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomas.肿瘤微环境对未分化多形性肉瘤患者新辅助化疗病理反应的预测价值。
J Hematol Oncol. 2024 Oct 23;17(1):100. doi: 10.1186/s13045-024-01614-w.